TRILEPTAL 300 mg, film-coated tablet 50 tablets
Brand page: Trileptal (oxcarbazepine) — all forms and strengths in France
Active ingredients: Oxcarbazepine
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet50 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TRILEPTAL 300 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium PVDC polyéthylène de 50 comprimé(s)
- Marketing authorisation holder
- NOVARTIS PHARMA
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Mar 2001
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61556061CIP73535724CIP133400935357243Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OXCARBAZÉPINEcomprimé | 300 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.